Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Authors

Brian T. Hill (ORCID: https://orcid.org/0000-0001-8781-3327)
Allison Winter (ORCID: https://orcid.org/0000-0002-8437-7539)
Robert M. Dean (ORCID: https://orcid.org/0000-0003-2559-563X)
Paolo F. Caimi (ORCID: https://orcid.org/0000-0003-1436-0464)
Hiruni Mendries
Deepa Jagadeesh
Taylor Brooks (ORCID: https://orcid.org/0009-0007-4352-9296)
Willem van Heeckeren
Chieh‐Lin Fu (ORCID: https://orcid.org/0000-0003-3664-3449)
Olivia Landever

Institutions

Cleveland Clinic (US)
Cleveland Clinic Florida (US)

Publication Details

Journal: Blood
Published: 2024-11-05
DOI: https://doi.org/10.1182/blood-2024-200306
Citations: 2
Primary Topic: Chronic Lymphocytic Leukemia Research
Type: article
Field-Weighted Citation Impact: 0.88

Funders

AstraZeneca
BeiGene
Swedish Orphan Biovitrum
Genentech
Pharmacyclics

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Brian T. Hill, Allison Winter, Robert M. Dean, Paolo F. Caimi et al.

Nov 5, 2024

2 citations

Blood

Chronic Lymphocytic Leukemia Research

0.88

article

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Brian T. Hill, Allison Winter, Robert M. Dean, Paolo F. Caimi, Hiruni Mendries, Deepa Jagadeesh, Taylor Brooks, Willem van Heeckeren, Chieh‐Lin Fu, Olivia Landever

November 5, 2024article en

2 citations

Abstract

No abstract available for this paper.

BloodVol. 144(Supplement 1)

Cleveland Clinic (US), Cleveland Clinic Florida (US)

AstraZeneca, BeiGene, Swedish Orphan Biovitrum, Genentech, Pharmacyclics

Openalex Percentile: Top 22%

Chronic Lymphocytic Leukemia Research

0.88

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq® — Brian T. Hill, Allison Winter, et al. · Blood (2024) | TGRS Research Map | TGRS